BIOXIS PHARMACEUTICALS
DEAD

Serial Number

79265623

Owner

BIOXIS Pharmaceuticals

Filing Date

May 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BIOXIS PHARMACEUTICALS Trademark

Serial Number: 79265623

BIOXIS PHARMACEUTICALS is a trademark filed by BIOXIS Pharmaceuticals on May 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BIOXIS Pharmaceuticals (6 trademarks)

317 Avenue Jean Jaurès
Lyon 69007 , FR

Entity Type: 16

Trademark Details

Filing Date

May 15, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector product

Surgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volume

Scientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical products

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 30, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 27, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 30, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 30, 2020 ABN2
REFUSAL PROCESSED BY IB
Oct 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2019 REPR